Filing Flows › Arcturus Therapeutics Holdings (ARCT) › Who owns the stock
Who owns Arcturus Therapeutics Holdings (ARCT) stock
131 funds reported Arcturus Therapeutics Holdings (ARCT) shares in their latest 13F filings, worth $184M in all. The largest holder is Federated Hermes ($22.2M). Last quarter 70 funds added to their stakes and 43 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Federated Hermes | 3,303,640 | $22.2M | unchanged | 2026-06-30 |
| ARK Investment Management LLC | 2,901,635 | $19.5M | increase | 2026-06-30 |
| BlackRock | 2,614,012 | $17.6M | increase | 2026-06-30 |
| Sumitomo Mitsui Trust Group | 1,963,123 | $13.2M | decrease | 2026-06-30 |
| Nikko Asset Management Americas | 1,960,458 | $13.1M | decrease | 2026-06-30 |
| Vanguard Group | 2,089,641 | $12.8M | increase | 2025-12-31 |
| Vanguard Capital Management LLC | 1,114,956 | $7.5M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 1,091,137 | $7.3M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 951,575 | $6.4M | decrease | 2026-06-30 |
| Hennion & Walsh Asset Management | 349,102 | $4.8M | increase | 2026-09-30 |
| Geode Capital Management, LLC | 693,660 | $4.7M | increase | 2026-06-30 |
| AQR Capital Management LLC | 675,014 | $4.5M | increase | 2026-06-30 |
| Jacobs Levy Equity Management | 647,511 | $4.4M | increase | 2026-06-30 |
| State Street | 569,598 | $3.8M | increase | 2026-06-30 |
| UBS Group AG | 490,632 | $3.3M | increase | 2026-06-30 |
Arcturus Therapeutics Holdings' latest quarter
Arcturus Therapeutics Holdings, Q3 2026: revenue $18.3M (+7% year over year), operating margin -50.2%, net loss $7.4M, operating cash flow −$6.9M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ARCT stock?
By the latest 13F filings: Federated Hermes ($22.2M); ARK Investment Management LLC ($19.5M); BlackRock ($17.6M); Sumitomo Mitsui Trust Group ($13.2M); Nikko Asset Management Americas ($13.1M).
What is the short interest in ARCT?
5,459,944 shares were sold short at the 2026-10-15 settlement, 1.52% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.